After controlling age, gender and other clinicopathological factors, we identified 44 NAT-induced differentially expressed genes (DEGs) in carcinoma AOIs, including 22 upregulated and 22 downregulated (Figure 2A, Supplementary Data 2). The gene discussed is BRD2; the disease is carcinoma.